SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-291529
Filing Date
2015-08-14
Accepted
2015-08-14 14:18:56
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d52828d10q.htm 10-Q 601006
2 EX-31.1 d52828dex311.htm EX-31.1 5531
3 EX-31.2 d52828dex312.htm EX-31.2 5579
4 EX-32.1 d52828dex321.htm EX-32.1 4454
  Complete submission text file 0001193125-15-291529.txt   3629894

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vktx-20150630.xml EX-101.INS 617004
6 XBRL TAXONOMY EXTENSION SCHEMA vktx-20150630.xsd EX-101.SCH 42880
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20150630_cal.xml EX-101.CAL 50640
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20150630_def.xml EX-101.DEF 156209
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20150630_lab.xml EX-101.LAB 368959
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20150630_pre.xml EX-101.PRE 267263
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 151054801
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences